Etalon Group PLC
F:2ET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Etalon Group PLC
F:2ET
|
CY |
|
C
|
Citizens Financial Corp
OTC:CFIN
|
US |
|
Public Policy Holding Company Inc
F:PD70
|
US |
|
3P Learning Ltd
F:73P
|
AU |
|
R
|
Reliance Weaving Mills Ltd
KAR:REWM
|
PK |
|
I
|
ITTEFAQ Iron Industries Ltd
KAR:ITTEFAQ
|
PK |
|
Elemental Royalty Corp
F:A980
|
CA |
|
A
|
Adaptin Bio Inc
OTC:APTN
|
US |
|
A
|
Adhera Therapeutics Inc
OTC:ATRX
|
US |
|
CCSB Financial Corp
OTC:CCFC
|
US |
|
Coeur d' Alene Bancorp Inc
OTC:CDAB
|
US |
|
A
|
Arno Therapeutics Inc
OTC:ARNI
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2ET's stock price target?
Not Available
2ET does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Etalon Group PLC?
Projected CAGR
16%
Over the last 5 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 1 year is 16%.
What is the Operating Income forecast for Etalon Group PLC?
Projected CAGR
-28%
Over the last 5 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 1 year is -28%.
What is the Net Income forecast for Etalon Group PLC?
Projected CAGR
-58%
Over the last 5 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 1 year is -58%.